2Wall SJ;Sampson MJ;Levell N.Elevated matrix metalloproteinase2 and -3 production from human idabetic dermal fibroblasts[J],2003(01).
3Lobmann R;Ambrosch A;Schultz G.Expression of matrix metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients[J],2002(07).
4Bickenbach JR;Grinnel KL.Epidermal stem cells:interactions in developmental environments,2004(08).
5Zhang F;Lei M P;Oswald T M.The effect of vascular endothelial growth factor on the healing of ischaemic skin wounds[J],2003(04).
6Wertheimer E;Spravchikov N;Trebicz M.The regulation of skin proliferation and differentiation in the IR mouse:implications for skin complication of diabetes[J],2001(03).
7Abdul-Ghani M;Nswaf G;Nawaf F;Itzhak B Minuclin O Vardi P.Increased prevalence of microvascular compliations in type 2 diabetes patients with the metabolic syndrome,2006(06).
8Schramm JC;Dinh T;Veves A.Microvascular changes in the diabetic foot,2006(03).
9Chong ZZ;Shang YC;Maiese K.Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling[J],2007(03).
10Yamaguchi Y;Passeron T;Hoashi T.Dickkopf 1(DKK1)regulates skin pigmentation and thickness by affecting Wnt/beta-catenin sigsaling in keratinocytes,2008(04).
